• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

GHX Acquires Syft, AI-Powered Hospital Supply Chain Platform

by Fred Pennic 02/28/2022 Leave a Comment

GHX Acquires Syft, AI-Powered Hospital Supply Chain Platform

What You Should Know:

– Today GHX announced its acquisition of Syft, a leading provider of AI-enhanced inventory control and end-to-end supply chain management software and services. 

– As a wholly-owned subsidiary of GHX, Syft joins GHX’s value-based care division’s growing portfolio of solutions that help modernize the supply chain.


Modernizing Healthcare Supply Chain to Overcome COVID-19 Related Challenges

As health systems shift to value-based care as well as overcome COVID-19-related challenges, it’s vital to modernize the supply chain with the technology, processes and people needed for data-driven decision-making, end-to-end visibility, automation and collaboration. – Syft helps health systems remove complexity and optimize the supply chain from dock-to-doc – from warehousing and distribution to the clinical point of use. Combining Syft’s approach to automation-driven supply chain management with GHX’s extensive network and collection of data will help healthcare leaders transform the supply chain to better meet the demands of a value-based future.  

Syft represents the third acquisition GHX has made in the last two years that is focused on advancing healthcare’s movement to value-based care. In October 2021, GHX added Explorer Surgical, operator of a comprehensive digital and remote case support platform, and Lumere, provider of evidence-based data and analytics, in January 2020. Financial terms of the acquisition were not disclosed. Cleary Gottlieb Steen & Hamilton LLP acted as legal advisor to GHX. McDermott Will & Emery acted as legal advisor to Syft. 

“To combat these challenges and accelerate the shift to value-based care, health systems need to transform the supply chain from a cost center to a value-driver,” said Bruce Johnson, president and CEO, GHX. “Forward-thinking leaders are investing in the digital transformation of the supply chain with the technology, data and processes required for greater collaboration, automation, visibility and data-driven decision-making. Syft provides the data and insight health systems need to reduce costs, improve efficiency and support care transformation.”

Tagged With: AI, Artificial Intelligence, digital transformation, ExplORer Surgical, GHX, GHX Healthcare, Health Systems, Healthcare Leaders, Healthcare Mergers & Acquisitions, Healthcare Supply Chain, Hospital Supply Chain, Value-Based Care, Vital

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |